Toxic shock syndrome: Case report of a postpartum female and a literature review

Journal of Emergency Medicine

Volumn 16, Issue 4, 1998, Pages 607-614

  Davis, Daniel ^a,b,c   Gash Kim, Tami L ^a,b   Heffernan, Edwin J ^b   Wulfert, Elizabeth ^c  

^a San Diego   (United States)

^b SCRIPPS MERCY HOSPITAL   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Postpartum infections; Sepsis; Staphylococcus aureus; Toxic shock syndrome

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN; CEFTRIAXONE; CLINDAMYCIN; DOPAMINE; DOXYCYCLINE; IBUPROFEN; NAFCILLIN; PARACETAMOL; PHENYLEPHRINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FEVER; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUERPERIUM; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME;

ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; FEMALE; HUMANS; NAFCILLIN; PENICILLINS; PUERPERAL INFECTION; SHOCK, SEPTIC;

EID: 0032127116     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(98)00056-0     Document Type: Article

References (81)

1. Shands K.N., Schmid G.P., Dan B.B., et al. Toxic-shock syndrome in menstruating women association with tampon use and S. aureus and clinical features in 52 cases . N Engl J Med. 303:1980;1436-1442.
2. Davis J.P., Chesney P.J., Wand P.J., et al. Toxic shock syndrome epidemiologic features, recurrence, risk factors, and prevention . N Engl J Med. 303:1980;1429-1435.
3. Reingold A.L., Shands K.N., Dans B.B., Broome C.V. Toxic-shock syndrome not associated with menstruation. Lancet. 1:1982;1-4.
4. Bartlett P., Reingold A.L., Graham D.R., et al. Toxic shock syndrome associated with surgical wound infections. JAMA. 247:1982;1448-1450.
5. Dornan K.J., Thompson D.M., Conn A.R., et al. Toxic shock syndrome in the postoperative patient. Surg Gynecol Obstet. 154:1982;65-68.
6. Graham D.R., O'Brien M., Hayes J.M., Raab M.G. Postoperative toxic shock syndrome. Clin Infect Dis. 20:1995;895-899.
7. Bracero L., Bowe E. Postpartum toxic shock syndrome. Am J Obstet Gynecol. 143:1982;478-479.
8. Whitfield J.W., Valenti W.M., Magnussen C.R. Toxic shock syndrome in the puerperium. JAMA. 246:1981;1806-1807.
9. Noronha S., Yue C.T., Sekosan M. Puerperal group A beta-hemolytic streptococcal toxic shock-like syndrome. Obstet Gynecol. 88:1996;728.
10. Kass E.J., Parsonnet J. On the pathogenesis of toxic shock syndrome. Rev Infect Dis. 9:1987;482-489.
11. Stevens D.L., Tanner M.H., Einship J., et al. Severe group A streptococcal infections associated with a toxic-shock-like syndrome and scarlet fever toxin A. N Engl J Med. 321:1989;1-8.
12. Blomqvist L. Toxic shock syndrome after burn injuries in children. Scand J Plastic Reconst Surg Hand Surg. 31:1997;77-81.
13. Ingraham H.J., Ryan M.E., Burns J.T., et al. Streptococcal preseptal cellulitis complicated by the toxic Streptococcus syndrome. Ophthalmology. 102:1995;1223-1226.
14. Mills W.J., Swiontkowski M.F. Fatal group A streptococcal infection with toxic shock syndrome complicating minor orthopedic trauma . J Orthop Trauma. 16:1996;1-20.
15. A streptococcus pneumonia associated with toxic shock syndrome - Quebec. Canada Commun Dis Rep. 22:1996;41-43.
16. Britto J., Habibi P., Walters S., Levin M., Nadel S. Systemic complications associated with bacterial tracheitis. Arch Dis Child. 74:1996;249-250.
17. Allen S.T., Liland J.B., Nichols C.G., Glew R.H. Toxic shock syndrome associated with use of latex nasal packing. Arch Intern Med. 150:1990;2587-2588.
18. Ferguson M.A., Todd J.K. Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children. J Infect Dis. 161:1990;953-955.
19. Dann E.J., Weinberger M., Gillis S., Parsonnet J., Shapiro M., Moses A.E. Bacterial laryngotracheitis associated with toxic shock syndrome in an adult. Clin Infect Dis. 18:1994;437-439.
20. Reduced incidence of menstrual toxic-shock syndrome - United States 1980-1990 . MMWR. 39:1990;421-423.
21. Friedell S., Mercer L.J. Nonmenstrual toxic shock syndrome. Obstet Gynecol Surv. 41:1986;336-341.
22. Langmuir A.D., Worthen T.D., Solomon J., et al. The Thucydides syndrome a new hypothesis for the cause of the plague of Athens . N Engl J Med. 313:1985;1027-1030.
23. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-Group 1 staphylococci. Lancet. 2:1978;1116-1118.
24. Follow-up on toxic-shock syndrome - United States. MMWR. 29:1980;297.
25. Toxic shock syndrome - United States, 1970-1982. MMWR. 31:1982;201.
26. Schlievert P.M., Shands K.N., Dan B.B., et al. Identification and characterization of an exotoxin from S. aureus associated with toxic-shock syndrome. J Infect Dis. 143:1981;509-516.
27. Bergdoll M.S., Crass B.A., Reiser R.J., et al. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome, S. aureus isolates. Lancet. 1:1981;1017-1021.
28. Kreiswirth B.N., Lafdahl S., Betley M.J., et al. The toxic shock syndrome gene is not detectably transmitted by a prophage. Nature. 305:1983;709-712.
29. Berkley S.F., Hightower A.W., Broome C.V., Reingold A.L. The relationship of tampon characteristics to menstrual toxic shock syndrome. JAMA. 258:1987;917-920.
30. Schlech W.F., Shands K.N., Reingold A.L., et al. Risk factors for development of toxic shock syndrome association with a tampon brand . JAMA. 248:1982;835-839.
31. Gaventa S., Reingold A.L., Hightower A.W., et al. Active surveillance for toxic shock syndrome in the United States - 1986. Rev Infect Dis. 12:1989;35-42.
32. Cone L.A., Woodard D.R., Schlievert P.M., Tomory G.S. Clinical and bacteriologic observations of a toxic-shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 317:1987;146-149.
33. Sellars B.J., Woods M.L., Morris S.E., Saffle J.R. Necrotizing group A streptococcal infections associated with streptococcal toxic shock syndrome. Amer J Surg. 172:1996;523-527.
34. Hribalova V. Streptococcus pyogenes and the toxic-shock syndrome. Ann Intern Med. 108:1988;772.
35. Bartter T., Dascal A., Carroll K., Curley F.J. Toxic strep syndrome. Arch Intern Med. 148:1988;1421-1424.
36. Bergovac J., Marton E., Lisic M., et al. Group A beta-hemolytic streptococcal toxic shock-like syndrome. Pediatr Infect Dis J. 9:1990;369-370.
37. Stevens D.L. Streptococcal toxic-shock syndrome spectrum of disease, pathogenesis, and new concepts in treatment . Emerging Infectious Dis. 1:1995;69-78.
38. Davies H.D., Kirk V., Jadavji T., Kotzin B.L. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Ped Infect Dis. 15:1996;1136-1138.
39. Leung D.Y., Meissner C., Fulton D., Schlievert P.M. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol. 15:1995;11S-17S.
40. Abinun M., Cant A.J. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 343:1994;300.
41. Doctor A., Harper M.B., Fleisher G.R. Group A beta-hemolytic streptococcal bacteremia historical overview, changing incidence, and recent association with varicella . Pediatrics. 96:1995;428-433.
42. Bradley J.S., Schlievert P.M., Sample T.G. Streptococcal toxic shock-like syndrome as a complication of varicella. Ped Infect Dis. 10:1991;77-79.
43. Bennett J.V. Toxins and toxic-shock syndrome. J Infect Dis. 143:1981;631-632.
44. Crass B.A., Bergdoll M.S. Toxin involvement in toxic shock syndrome. J Infect Dis. 153:1986;918-926.
45. Bartlett J.G., Onderdonk A.B., Drude E., et al. Quantitative bacteriology of the vaginal flora. J Infect Dis. 136:1977;271-277.
46. Tasjian J.H., Coulan C.B., Washington J.A. Vaginal flora in asymptomatic women. Mayo Clin Proc. 51:1976;557-561.
47. Ohm M.J., Galask R.P. Bacterial flora of the cervix from 100 prehysterectomy patients. Am J Obstet Gynecol. 122:1975;683-687.
48. Guinan M.E., Dan B.B., Guidott R.J., et al. Vaginal colonization with Staphylococcus aureus in healthy women. Ann Intern Med. 96:1982;944-947.
49. Larsen B., Schlievert P.M. TSS the mystery unfolds . Contemp Obstet Gynecol. 18:1981;219-229.
50. Noble V.S., Jacobson J.A., Smith C.B. The effect of menses and use of catamenial products on cervical carriage of Staphylococcus aureus. Am J Obstet Gynecol. 144:1982;186-189.
51. Saunders C.C., Saunders W.E., Fagnant J.E. Toxic shock syndrome an ecologic imbalance within the genital microflora of women? Am J Obstet Gynecol. 142:1982;977-982.
52. Wagner G., Bohr L., Wagner P., Petersen L.N. Tampon induced changes in vaginal oxygen and carbon dioxide tensions. Am J Obstet Gynecol. 148:1984;147-150.
53. Mill J.T., Parsonnet J., Tsai Y.-C., et al. Control of production of toxic-shock syndrome toxin-1 (TSST-1) by magnesium ion. J Infect Dis. 151:1985;1158-1161.
54. Kiyota H., Kendrick M.I., Kass E.H. Influence of magnesium concentration on production of exoprotein and B-lactamase by S. aureus and Staphylococcus hemolyticus. J Infect Dis. 160:1989;1061-1063.
55. Kass E.H. Magnesium and the pathogenesis of toxic shock syndrome. Rev Infect Dis. 11:1989;167-175.
56. Schlievert P.M., Blomster D.A., Kelly J.A. Toxic shock syndrome Staphylococcus aureus effect of tampons on toxic shock syndrome toxin-1 production . Obstet Gynecol. 64:1984;666-671.
57. Kehrberg M.W., Latham R.H., Haslam B.T., et al. Risk factors for staphylococcal toxic shock syndrome. Am J Epidemiol. 114:1981;873-879.
58. Ikejima T., Dinarello C.A., Gill D.M., Wolff S.M. Induction of human IL-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest. 73:1984;1312-1320.
59. Parsonnet J., Hickman R.K., Eardley D.D., Pier G.B. Induction of human IL-1 by toxic shock syndrome toxin-1. J Infect Dis. 151:1985;514-522.
60. Fast D.J., Schlievert P.M., Nelson R.D. Toxic-shock syndrome-associated staphylococcal pyrogenic toxins are potent inducers of TNF production. Infect Immun. 57:1989;291-294.
61. Buyalos R.P., Rutanen E.-M., Tsui E., Halme J. Release of TNF alpha by human peritoneal macrophages in response to toxic-shock syndrome toxin-1. Obstet Gynecol. 78:1991;182-186.
62. Schlievert P.M. Searching for superantigens. Immunol Invest. 26:1997;283-290.
63. Jabara H.H., Geha R.S. The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching. Intern Immunol. 8:1996;1503-1510.
64. Nadal D., Lauener R.P., Braegger C.P., et al. T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J Pediatrics. 122:1993;727-729.
65. Brigham K.L. Oxygen radicals - an important mediator of sepsis and septic shock. Klin Wochenschrift. 69:1991;1004-1008.
66. Sweet RL, Gibbs RS. Toxic shock syndrome. In: Sweet RL, Gibbs RS, eds. Infectious diseases of the female genital tract. Baltimore: Williams & Wilkins; 1995;321 40.
67. Chiu C.H., Lin T.Y., Wu J.L. Acute pancreatitis associated with streptococcal toxic shock syndrome. Clin Infect Dis. 22:1996;724-726.
68. McMahon W.S., Patrenos M.E., McConnell M.E., Tilden S.J. Complete heart block in toxic shock syndrome. Amer J Dis Child. 144:1990;748-750.
69. Schlossberg D. A possible pathogenesis for recurrent toxic shock syndrome. Am J Obstet Gynecol. 141:1981;348-349.
70. Chesney P.J., Crass B.A., Polyak M.B., et al. Toxic-shock syndrome management of long-term sequelae . Ann Intern Med. 96:1982;847-851.
71. Tiengo M. Naloxone in irreversible shock. Lancet. 2:1980;690.
72. Peters W.P., Friedman P.A., Johnson M.W., et al. Pressor effect of naloxone in septic shock. Lancet. 1:1981;529-532.
73. Stevens D.L. Could nonsteroidal antiinflammatory drugs (NSAIDS) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 21:1995;977.
74. Melish M.E., Frogner K., Hirata S., Murata M.S. Use of IVIG for therapy in the rabbit model of TSS. Clin Res. 35:1987;220.
75. Barry W., Hudgins L., Donta S.T., Pesanti E.L. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 267:1992;3315-3316.
76. Lamothe F., D'Amico P., Ghosn P., Tremblay C., Braidy J., Patenaude J.V. Clinical usefulness of i.v. human immunoglobulins in invasive group A Streptococcal infections case report and review . Clin Infect Dis. 21:1995;1469-1470.
77. Krakauer T. Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by IL-10, IL-4, and dexamethasone. J Infect Dis. 172:1995;988-992.
78. Barton B.E., Shortall J., Jackson J.V. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun. 64:1996;714-718.
79. Sriskandan S., McKee A., Hall L., Cohen J. Comparative effects of clindamycin and ampicillin on superantigen activity of Streptococcus pyogenes. J Antimicrob Chemother. 40:(2):1997;275-277.
80. van Langervelde P., van Dissel J.T., Meurs C.J., et al. Combination of flucloxacillin and gentamycin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth. Antimicro Agents Chemother. 41:(8):1997;1682-1685.
81. Rosene K.A., Copass M.K., Kastner L.S., et al. Persistent neuropsychological sequelae of toxic shock syndrome. Ann Intern Med. 96:1982;865-870.